SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

Am J Clin Nutr. 2023;117(5):910-917.

PNPLA3 genotypes modify the adverse effect of the total energy intake on high-risk nonalcoholic steatohepatitis development.

, , , , , , , ,

제1저자 손희준, 구보경 · 교신저자 김원

소속 (5)
  1. Division of Endocrinology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  2. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; Division of Endocrinology, Department of Internal Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul, Korea.
  3. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul, Korea.
  4. Department of Pathology, Seoul National University College of Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul, Korea.
  5. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul, Korea. Electronic address: drwon1@snu.ac.kr.

Abstract

BACKGROUND The relationship between diet and risk genotypes in nonalcoholic steatohepatitis (NASH) development and fibrosis progression in patients with nonalcoholic fatty liver disease (NAFLD) remains unclear.

OBJECTIVE We aimed to investigate the effects of diet on NASH development and fibrosis progression in patients with NAFLD stratified by the PNPLA3 genotype.

METHODS We performed a prospective study in a cohort of patients with biopsy-confirmed NAFLD. Histologic deterioration was obtained using serial transient elastography at every 1 or 2 y. The primary outcome was fibrosis progression, and the secondary outcome was development of high-risk NASH, defined as FibroScan-aspartate aminotransferase score ≥0.67 during the follow-up of patients with nonalcoholic fatty liver at the baseline. Dietary intake was evaluated using a semiquantitative food frequency questionnaire.

RESULTS The primary outcome was observed in 42 (29.0%) of the 145 patients during a median follow-up of 49 mo; neither the total energy intake nor each macronutrient intake significantly affected the primary outcome occurrence. Conversely, the total energy intake (HR per 1-SD: 3.03; 95% CI: 1.31, 7.01) and the PNPLA3 rs738409 genotype [HR per 1 risk allele (G): 2.06; 95% CI: 1.11, 3.83)] were independent risk factors for high-risk NASH. The significant interaction between the total energy intake and PNPLA3 genotype was noted in developing high-risk NASH (P = 0.044). As the number of PNPLA3 risk alleles decreased, the effect of the total energy intake on high-risk NASH increased; the HR per 1-SD increment in total energy intake was 1.52 (95% CI: 0.42, 5.42), 3.54 (95% CI: 1.23, 10.18), and 8.27 (95% CI: 1.20, 57.23) for the GG, CG, and CC genotypes, respectively.

CONCLUSIONS The total energy intake adversely affected the development of high-risk NASH in patients with biopsy-confirmed NAFLD. The effect was more prominent in patients without the PNPLA3 risk allele, highlighting the importance of personalized dietary interventions in NAFLD treatment.

Copyright © 2023 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.

Keywords

PNPLA3carbohydrateliver fibrosisnonalcoholic fatty liver diseasenutrition

그 밖의 정보
출판 형태
Journal Article, Research Support, Non-U.S. Gov't
저널
The American journal of clinical nutrition · eISSN 1938-3207
전자 출판
2023-03-05
MeSH
Humans · Drug-Related Side Effects and Adverse Reactions* · Energy Intake · Fibrosis · Genetic Predisposition to Disease · Non-alcoholic Fatty Liver Disease* / genetics / epidemiology · Polymorphism, Single Nucleotide · Prospective Studies · Acyltransferases · Phospholipases A2, Calcium-Independent
Substances
PNPLA3 protein, human · Acyltransferases · Phospholipases A2, Calcium-Independent